These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6783679)

  • 21. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
    Johansen HK; Høiby N; Pedersen SS
    APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obtention and assay of rabbit anti-Pseudomonas serum.
    Laborde HF; Legnani de Fajardo C
    J Bacteriol; 1969 Jun; 98(3):992-5. PubMed ID: 4182531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antibody response to the flagella of Pseudomonas aeruginosa.
    Pitt TL; Bradley DE
    J Med Microbiol; 1975 Feb; 8(1):97-106. PubMed ID: 805246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity of Pseudomonas aeruginosa antipilin monoclonal antibodies with heterogeneous strains of P. aeruginosa and Pseudomonas cepacia.
    Saiman L; Sadoff J; Prince A
    Infect Immun; 1989 Sep; 57(9):2764-70. PubMed ID: 2569448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
    Aronoff SC; Stern RC
    J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
    Berk RS; Preston M; Montgomery IN; Hazlett LD; Tse HY
    Reg Immunol; 1990-1991; 3(4):186-92. PubMed ID: 2129603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
    Zaĭdner IG; Stanislavskiĭ ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa Infection.
    Shigeta S; Yasunaga Y; Ogata M
    J Clin Microbiol; 1978 Nov; 8(5):489-95. PubMed ID: 103887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic relationship between the common antigen (OEP) of Pseudomonas aeruginosa and Vibrio cholerae.
    Hirao Y; Homma JY
    Infect Immun; 1978 Feb; 19(2):373-7. PubMed ID: 75846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological and biological relationship among flagellin of Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia.
    Zgair AK; Chhibber S
    Mikrobiologiia; 2012; 81(3):371-6. PubMed ID: 22880399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
    Podgornaia LG; Dziuban NF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of antibody response and immunoglobulins in sera of rabbits and guinea pigs immunized with Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1977 May; 21(3):246-55. PubMed ID: 18924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.
    Pollack M; Callahan LT; Taylor NS
    Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Pseudomonas haemolysin. III. Properties of antilysin serum.
    Lochmann O; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):224-9. PubMed ID: 809503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunochemical study of a strain of Pseudomonas aeruginosa].
    Stefanini AM; Frigerio M
    Rev Latinoam Microbiol; 1981; 23(2):103-7. PubMed ID: 6798663
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerability and immunogenicity of a polyvalent Pseudomonas aeruginosa extract vaccine in human volunteers.
    Martindale JJ; Ganzinger U; Steinmüller W; Millendorfer A; Ambrosch F; Kollaritsch H; Wiedermann G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):376-85. PubMed ID: 3136608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.